LINC00029

Across TCGA pan-cancer cohorts, LINC00029 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC00029 data layer compared with 1 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC00029 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00029 expression acts as an unfavorable survival marker, although some lineages such as SKCM and READ show a favorable association.

ACC, THCA, and CHOL are the cancer types where LINC00029 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.083	0.625	<.001	155	view →
THCA	OS	Tertile	II,III,IV	0.217	0.845	<.001	54	view →
CHOL	DFS	Tertile	II,III,IV	0.032	0.477	<.001	45	view →
SKCM	DFS	Tertile	All	0.709	0.599	.012	39	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
LIHC	OS	Tertile	All	0.550	0.793	.009	30	view →
READ	DFS	Tertile	III,IV	0.587	0.208	.013	24	view →
UCS	OS	Tertile	IV	0.269	0.624	.042	18	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
THYM	OS	Median	All	1.000	0.665	.007	16	view →
KIRP	OS	Tertile	All	0.541	0.825	.048	12	view →
UVM	DFS	Tertile	II,III,IV	0.328	0.637	.047	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC00029–ACC (DFS)

Open the ACC breakdown →